Radiology • Image-Guided Procedures

Ultrasound-Guided Biopsy and Aspiration

Also called: USG-Guided FNAC • Core Needle Biopsy • Image-Guided Aspiration • Percutaneous Sampling

Ultrasound guidance allows the radiologist to see a lump, organ or fluid collection and the needle in real time. It helps select a path that reaches the target while avoiding visible blood vessels and other important structures—and does so without ionising radiation.

A biopsy removes cells or tissue for laboratory diagnosis. An aspiration removes fluid for testing, symptom relief or both. These are not interchangeable procedures, and preparation, risks, observation and results depend strongly on the target and the exact needle technique planned.

Serious complications are uncommon but need prompt recognition

Seek Urgent Help for Breathing Difficulty, Heavy Bleeding or Rapidly Worsening Symptoms

Contact the procedure team urgently or attend emergency care after biopsy or aspiration if you develop:

  • Breathlessness, chest pain, coughing blood, blue or grey colour, fainting or collapse.
  • Heavy or persistent bleeding, an enlarging tense swelling, large clots, marked dizziness or cold, clammy skin.
  • Rapid neck swelling, noisy breathing, difficulty swallowing, a new voice change or inability to lie flat.
  • Severe or increasing chest, abdominal, flank, shoulder, pelvic or back pain.
  • Fever, shaking chills, confusion, pus, spreading redness or rapidly worsening tenderness.
  • Visible blood in urine with clots, inability to pass urine or severe flank pain after a renal or urinary procedure.
  • New weakness, numbness, severe swelling or loss of colour or warmth beyond the procedure site.

The warning signs differ by body site. Follow the discharge sheet supplied for your procedure and do not drive yourself when you feel faint, breathless or acutely unwell. A small bruise or mild soreness can be expected; rapid deterioration is not routine aftercare.

First Check: Which Procedure Has Been Requested?

Fine needle aspiration cytology (FNAC / FNA) A very fine needle removes loose cells and sometimes fluid. A cytology laboratory examines individual cells or small clusters. It is commonly used for selected thyroid, lymph-node, salivary and superficial lesions.
Core needle biopsy (CNB) A spring-loaded or automated needle removes slender cylinders of tissue. Histology preserves tissue architecture and may allow grading, immunohistochemistry or molecular testing when enough suitable tissue is obtained.
Diagnostic fluid aspiration A needle withdraws fluid for microbiology, cytology or biochemical analysis. The colour or thickness of the fluid cannot establish the diagnosis by appearance alone.
Therapeutic aspiration Fluid is removed to reduce pressure, pain or swelling—for example from a selected cyst, bursa or collection. The cavity or underlying cause may persist, so fluid can return.
Drainage-catheter placement A thin tube is left within a larger, infected or repeatedly filling collection for ongoing drainage. It requires separate catheter care and is more than a one-time needle aspiration.

“Ultrasound-Guided” Describes Navigation—not the Laboratory Test

The same ultrasound target could require FNAC, core biopsy, aspiration, culture or a combination. The referral should state the clinical question and required specimen. If the booking only says “USG-guided procedure,” ask which sample will be collected, where it will go and whether a drain may be left behind.

Why is Ultrasound Guidance Used?

Real-time needle visibility The needle can be watched as it approaches and enters the selected part of the target.
Safer route planning Grey-scale and Doppler help avoid visible vessels, nerves, bowel, lung and other structures.
Targeted sampling Solid, viable or otherwise suspicious areas can be selected instead of necrotic or purely fluid portions.
No ionising radiation Ultrasound guidance uses sound waves and can be repeated during the procedure.

Ultrasound is most useful when the target is clearly visible and a safe needle path exists. A lesion hidden by bone, lung air or bowel gas, or a deep target that cannot be reached safely, may require CT, mammographic, MRI, fluoroscopic, endoscopic or surgical guidance instead.

What Areas May Be Sampled or Aspirated?

Thyroid, salivary glands and neck nodes FNAC or core biopsy may investigate a selected nodule, gland mass or abnormal lymph node. Neck procedures require careful planning around vessels, nerves, airway and swallowing structures.
Breast and axillary nodes Core biopsy is frequently used for a solid ultrasound-visible lesion; aspiration may assess or relieve a cyst. A tiny marker clip may be placed after some breast biopsies for future localisation.
Superficial soft tissue Selected subcutaneous, muscular or other accessible masses can undergo core biopsy, while abscesses, haematomas or cystic lesions may be aspirated when clinically appropriate.
Liver, kidney and abdominal or pelvic targets Organ or mass biopsy can obtain tissue for diagnosis. Deeper procedures require laboratory review, route planning, longer observation and careful assessment of internal-bleeding risk.
Joints, bursae and periarticular collections Fluid can be aspirated to test for infection or crystals, reduce pressure or guide further treatment. A dry tap does not by itself exclude infection.
Abscesses and other fluid collections Small accessible collections may undergo one-time aspiration; larger, infected, thick or continuing collections may need catheter drainage, antibiotics or surgery.

Availability and suitability are decided only after the referral and imaging are reviewed. Not every lump should be punctured, and some suspected sarcomas or other tumours require specialist-planned biopsy so the needle track lies within the future surgical field.

How is the Needle Route Planned?

  • The target must be visible confidently on ultrasound in the procedure position.
  • The radiologist distinguishes solid, cystic, necrotic and vascular components and chooses the relevant part.
  • Colour Doppler maps visible vessels, although very small or slow-flow vessels may not be detected.
  • The shortest route is not always the safest; bowel, pleura, nerves, ducts and vital organs may need to be avoided.
  • The route must allow the needle tip to remain visible rather than relying on the expected line of the shaft.
  • Patient position and breath-holding may be adjusted to move the target or reduce organ motion.
  • If no safe window exists on the day, the procedure may be changed, postponed or referred for another guidance method.

Cancelling an unsafe approach is a safety decision, not a failed attempt. The radiologist and referring clinician decide whether different imaging, another access route, surgery or observation is the better next step.

How Should I Prepare?

Preparation is target-specific. A superficial thyroid or node FNAC may need almost none, while a deep organ biopsy or sedated drainage procedure can require fasting, blood tests, intravenous access and several hours of observation.

Bring the referral and previous imaging The exact body site, side, target and reason for sampling must match the images. Bring relevant ultrasound, mammogram, CT, MRI, PET and earlier pathology or culture reports.
Medicines and supplements Provide a complete list, especially antiplatelet, anticoagulant, anti-inflammatory, herbal or non-prescribed products that can affect bleeding.
Blood tests Platelet count and clotting tests may be checked for core or deep-organ procedures. Requirements depend on the target, needle size, bleeding risk, health history and medicine plan.
Food and drink Many superficial procedures need no fasting. Fasting is commonly required when sedation, anaesthesia or a deeper abdominal procedure is planned. Follow the written instructions for your appointment.
Travel home Arrange an adult escort and do not drive when sedation is planned or the team advises this for the procedure site. Sedation has separate restrictions for driving, decisions, alcohol and caring responsibilities.

Tell the team before the appointment about:

  • Any possibility of pregnancy.
  • A previous major bleed, clotting disorder, low platelets, liver disease or severe kidney disease.
  • Allergy or previous reaction to local anaesthetic, antiseptic, antibiotics, latex, dressings or sedation.
  • Current fever, skin infection, recent illness or antibiotics.
  • Diabetes or treatment that requires adjustment during fasting.
  • Sleep apnoea, severe lung or heart disease, implanted devices or difficulty lying in the required position.
  • Previous surgery, radiotherapy, biopsy or drainage at the target site.

Never Stop a Blood Thinner on Your Own

The safest plan balances two different harms: bleeding from the needle procedure and a stroke, heart attack, stent thrombosis, pulmonary embolism or other clot if protective medicine is interrupted. The answer depends on the drug, dose, kidney function, reason it was prescribed, procedure site and needle technique.

Low-risk superficial sampling Some fine-needle procedures can be performed without interrupting selected medicines, but this must be a documented decision by the responsible clinicians—not an assumption.
Core or deep-organ biopsy Often needs a more formal anticoagulant and antiplatelet plan and recent laboratory results. The timing differs among medicines and cannot be safely generalised on a web page.
If instructions conflict Contact the radiology team and the clinician who manages the medicine. Do not choose between two plans yourself, and do not take “stop all blood thinners” as a universal instruction.

What Happens During the Procedure?

1 Identity, site and procedure are confirmed

The team checks the referral, imaging, allergies, medicines, blood results and consent. The exact target and side are confirmed during a safety pause before the needle is introduced.

2 A planning ultrasound is performed

The radiologist confirms that the target remains visible and selects a safe route. Your position or breathing may be adjusted, and Doppler is used where relevant.

3 The skin is cleaned and draped

Antiseptic is applied and sterile equipment is used. Local anaesthetic is injected for most core biopsies and many aspirations; a brief sting and burning sensation can occur.

4 The needle is guided into the target

The probe and needle are aligned so the tip can be watched in real time. You may feel pressure. A core-biopsy device makes a sudden click when each sample is taken.

5 Samples are collected and labelled

Several needle passes may be needed. Cells, cores or fluid are placed in the correct containers for cytology, histology, microbiology, flow cytometry, molecular testing or fluid chemistry as requested.

6 Bleeding is checked and the site is dressed

The needle is removed, firm pressure is applied and a dressing is placed. Ultrasound may check for immediate bleeding or residual fluid before you enter the appropriate observation pathway.

The needle portion may be brief, but consent, planning, sterile preparation, specimen handling and observation make the total visit longer. Do not schedule around a quoted “five-minute biopsy” without the department's full time estimate.

What Will I Feel?

Local-anaesthetic injection A short sharp sting and burning sensation are common. The area then becomes numb, although pressure and movement can still be felt.
Fine needle aspiration Often feels similar to a blood test or several brief needle pricks. Local anaesthetic use varies with the site, number of passes and patient preference.
Core biopsy You may feel firm pressure and hear a loud click. Severe sharp pain should be reported immediately so the procedure can pause and anaesthesia or position can be reassessed.
Aspiration or drainage Pressure can reduce as fluid is removed. Thick or loculated material may drain incompletely, and a catheter can cause temporary pulling or cramping.

Where Does the Sample Go?

Cytology Examines cells from FNAC or fluid. Results may be benign, atypical, suspicious, malignant or non-diagnostic, using terminology specific to the sampled organ.
Histology Examines core tissue architecture. Additional stains, immunohistochemistry or molecular tests may be required after the initial microscope review.
Microbiology Tests aspirated fluid or tissue for bacteria, fungi or other organisms using microscopy, culture and sometimes molecular methods. Antibiotics taken beforehand can reduce culture yield.
Flow cytometry Evaluates cell populations when lymphoma or another blood-cell disorder is considered. The sample needs specific handling and must be planned before the procedure.
Fluid chemistry or crystal analysis May measure protein, glucose, enzymes or other markers, or look for crystals in joint fluid. The requested tests depend on the suspected diagnosis and body site.

One container cannot always serve every laboratory. Good results begin before the needle enters: the clinical question, specimen type, transport medium and destination should be agreed in advance.

What Happens Immediately Afterwards?

  • Firm pressure is applied to the puncture site and a small dressing is placed.
  • Superficial FNAC or aspiration may need only brief observation when you are well.
  • Core, solid-organ or deep procedures may require repeated vital signs and several hours of monitored rest.
  • A follow-up ultrasound, chest X-ray, urine check or blood test may be used for selected sites or symptoms.
  • Food, drink and regular medicines are restarted according to the procedure and sedation plan.
  • Written instructions should explain dressing care, bathing, activity, pain relief, medicine restart and emergency contact details.

Do not leave before you know when to restart any anticoagulant or antiplatelet medicine. The restart time is as important as the interruption plan and must come from the responsible team.

Risks Vary With the Target

All needle procedures Pain, bruising, bleeding, infection, fainting, injury to a nearby structure, failed access and an insufficient or non-diagnostic sample are possible.
Neck and thyroid Bruising and tenderness are most common. Significant neck bleeding, airway compression, nerve injury or voice change is uncommon but requires urgent assessment.
Breast and superficial soft tissue Bruising, haematoma, temporary lumpiness and soreness can occur. Infection and significant bleeding are uncommon; aspiration does not remove a cyst wall and recurrence is possible.
Liver, kidney and deep abdomen Internal bleeding is the main serious concern. Rare site-specific complications include injury to bowel or pleura, bile or urine leakage, infection and the need for transfusion, embolisation or surgery.
Chest, pleura or upper abdominal route If the pleura or lung is crossed, air can collect around the lung (pneumothorax), sometimes requiring observation, aspiration or chest-tube drainage.
Joint or bursal aspiration Temporary pain, bleeding and infection are possible. Failure to obtain fluid does not exclude infection, and symptoms may recur when the underlying condition persists.
Abscess aspiration or catheter drainage Bleeding, bloodstream infection, incomplete drainage, catheter blockage or displacement, fistula and repeat procedures can occur. Antibiotics or surgery may still be necessary.

What Do Common Procedure and Result Terms Mean?

Target lesion The specific lump, nodule, node, organ abnormality or fluid collection selected for sampling—not simply the general body region.
Solid / cystic / complex Solid contains tissue; cystic contains fluid; complex contains both or internal debris. Composition helps determine whether aspiration, core sampling or another approach is likely to answer the question.
Coaxial technique A guiding needle remains at the target while multiple core samples pass through it, reducing repeated traversal of the full skin-to-lesion route.
Passes / cores The number of separate needle sampling actions or tissue cylinders collected. More is not automatically better; adequacy depends on target biology and laboratory need.
Technically successful The needle reached the intended target and material was collected. This does not guarantee that the laboratory sample will be adequate or that aspiration will cure the underlying condition.
Adequate sample Enough appropriate cells or tissue are present for the intended analysis. On-site adequacy assessment is helpful for selected procedures but is not available or definitive in every case.
Non-diagnostic / insufficient The material cannot answer the clinical question—perhaps because it contains too few cells, only blood, necrosis or non-representative tissue. It is not the same as a benign result.
Benign No malignancy is identified and the sample supports a non-cancerous diagnosis. The team must still confirm that the pathology explains the imaging target.
Atypical / indeterminate Abnormal features are present but do not meet criteria for a definitive diagnosis. Repeat sampling, core biopsy, molecular testing, surgery or imaging follow-up may be recommended.
Suspicious for malignancy Findings strongly raise concern but are not fully definitive in the submitted material. Specialist review and additional tissue or treatment planning are usually required.
Malignant Cancer cells or tissue are identified. Additional typing, grading, biomarkers and staging investigations may be needed before treatment is selected.
Concordant / discordant Concordant means the pathology reasonably explains the imaging and clinical finding. Discordant means it does not; a benign-looking sample from a highly suspicious target may need repeat biopsy or surgery.
No growth on culture No organism grew under the laboratory conditions used. This does not always exclude infection, particularly after antibiotics or with small, difficult or slowly growing organisms.

Why Might Sampling Need to Be Repeated?

  • The sample was insufficient, non-diagnostic or contained only blood, fluid or necrotic material.
  • The lesion is heterogeneous and the first pass may not have captured the diagnostic component.
  • FNAC answered that cells are abnormal but core architecture is needed for classification.
  • Additional tissue is required for immunohistochemistry, molecular tests, microbiology or clinical trials.
  • The pathology is benign but does not match suspicious imaging or continued growth.
  • An aspiration relieved symptoms but the cyst or collection refilled.
  • An abscess remains loculated or continues to receive infected fluid from an untreated source.

Repeat sampling does not necessarily mean cancer was found. It means the first procedure did not completely answer the clinical question or the condition has changed.

What Can Ultrasound Guidance Not Guarantee?

  • That every lesion is visible or safely reachable with ultrasound.
  • That visible vessels are the only vessels along the needle route.
  • That a needle reaching the target will collect diagnostic tissue.
  • That a benign or negative sample represents the whole lesion when imaging and pathology disagree.
  • That aspiration permanently removes a cyst, bursa, haematoma or collection.
  • That infected fluid will resolve without antibiotics, catheter drainage, source control or surgery.
  • That fluid colour can distinguish infection, blood, lymph, bile, urine or malignant fluid without laboratory testing.
  • That lack of immediate bleeding excludes delayed bleeding after a deeper procedure.
  • That ultrasound alone provides the cancer type, grade, molecular profile or stage.

Myth vs Fact

Myth A needle biopsy routinely spreads cancer.
Fact Needle-track tumour seeding is a recognised but very uncommon complication for most appropriately planned biopsies. The diagnostic benefit usually greatly outweighs this small risk.
Myth FNAC, core biopsy and aspiration are different names for the same thing.
Fact FNAC provides cells, core biopsy provides tissue architecture and aspiration removes fluid. They answer different laboratory and treatment questions.
Myth Clear or straw-coloured fluid proves a cyst is harmless.
Fact Fluid appearance is not a diagnosis. Imaging features, recurrence and cytology, culture or chemistry—when indicated—determine what the fluid means.
Myth A technically successful biopsy guarantees a final diagnosis.
Fact Correct needle placement can still yield too few cells, necrosis or non-representative tissue. Laboratory adequacy and imaging-pathology concordance complete the assessment.
Myth I should stop every blood thinner before any needle procedure.
Fact Interruption depends on medicine, reason, target and bleeding risk. Stopping without a plan can cause a dangerous clot, stroke or heart problem.
Myth Ultrasound guidance exposes me to X-rays.
Fact Ultrasound uses sound waves, not ionising radiation. Another modality may be used only if the target or safe route cannot be shown adequately with ultrasound.

Frequently Asked Questions

Does the procedure hurt?

Local anaesthetic commonly causes a brief sting and then reduces sharp pain. Pressure, movement and a click during core biopsy can still be felt. Tell the radiologist about severe pain immediately.

Do I need to fast?

Many superficial FNAC, breast, thyroid, node or soft-tissue procedures need no fasting. Deep-organ procedures and those using sedation may require it. Follow the instructions for your exact booking.

Should I stop an antiplatelet or blood-thinning medicine?

Only if the procedure team and prescribing clinician give a specific plan. Do not stop or change any antiplatelet or anticoagulant medicine yourself.

Will I be awake?

Usually yes. Many procedures use local anaesthetic alone. Sedation or anaesthesia may be used for selected deep, prolonged, painful or paediatric procedures and comes with separate fasting and escort requirements.

How many needle passes will be needed?

It varies with FNAC versus core biopsy, target size, suspected diagnosis and laboratory needs. Several passes are common. The radiologist stops when the planned material is obtained or further sampling would be unsafe.

Can I drive home?

Not after sedation, and some deeper biopsies also require an escort or driving restriction. A simple superficial procedure may have fewer restrictions. Confirm this before the appointment rather than arranging transport afterward.

When can I return to work or exercise?

The answer depends on the site and needle. Light activity may resume soon after superficial sampling, while deep-organ biopsy commonly requires a longer restriction on strenuous exercise and lifting. Use the discharge sheet.

Why was a core biopsy chosen instead of FNAC?

Some diagnoses require tissue architecture, grading, immunohistochemistry or molecular testing. FNAC may be enough for selected lesions, while lymphoma, many solid masses and treatment planning often need core tissue.

Can aspiration cure a cyst or abscess?

Sometimes it provides lasting relief, but the lining or source remains and fluid can return. An abscess may require antibiotics, a drainage catheter, repeat intervention or surgery in addition to fluid removal.

What if no fluid comes out?

The material may be too thick, loculated or predominantly solid, or the cavity may have changed since prior imaging. A “dry tap” does not automatically exclude infection or disease; the plan is reassessed.

What does a non-diagnostic result mean?

It means the sample cannot answer the question. It does not mean normal or cancer-free. The team reviews the images, procedure and laboratory findings before recommending repeat sampling, another technique or follow-up.

Can a benign result ever need another biopsy?

Yes. If benign pathology does not explain a suspicious or enlarging imaging target, the result is discordant. Repeat core sampling, surgical biopsy or another specialist assessment may be safer than simple reassurance.

How long do results take?

Cytology, routine histology, cultures and specialised stains have different timelines. Some cultures require several days or longer; molecular and immunohistochemical tests may extend the final report. Ask who will communicate each result.

Will the radiologist tell me whether it is cancer immediately?

Usually not. Ultrasound confirms the target and guides sampling, but a pathologist must examine the specimen. Even an on-site adequacy check generally confirms material is present rather than providing the final diagnosis.

What should I bring to the appointment?

Bring the referral, relevant images and reports, medicine list, allergy information and requested blood results. Know who prescribed any anticoagulant and who will discuss the laboratory result with you.

A Note From Our Doctors

The information on this page is intended to help you understand your condition. It should not be considered a diagnosis or a substitute for a consultation with a qualified medical professional.

Every patient is unique. The same symptom can have different causes in different individuals, and the most appropriate investigations and treatment depend on your medical history, examination findings, age, existing medical conditions and test results.

At SR Speciality Hospital, we believe in treating the whole patient—not just a symptom, scan or laboratory report. Every treatment plan is individualised after careful medical evaluation.

Radiology Procedure Referrals

Have you been advised to undergo an ultrasound-guided biopsy or aspiration?

Contact the hospital with the referral, previous imaging, medicine list and requested laboratory test. Mention every blood thinner, bleeding disorder, allergy, infection symptom and whether sedation or a drainage catheter has been discussed.